Organogenesis Holdings Inc. ORGO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $37.23M-57.1% | $225.61M+78.1% | $150.86M+31.0% | $101.01M-22.4% | $86.69M-21.2% | ||
| $15.16M+42.5% | $10.29M-10.8% | $13.22M+27.8% | $10.4M-33.3% | $10.64M-16.9% | ||
| $65.19M-10.1% | $100.17M+35.6% | $79.74M+11.1% | $73.81M-3.6% | $72.51M+0.3% | ||
| $106.12M-6.5% | $162.32M+39.4% | $130.14M+19.5% | $113.58M-21.2% | $113.44M+33.3% | ||
| $106.12M-6.5% | $162.32M+39.4% | $130.14M+19.5% | $113.58M-21.2% | $113.44M+33.3% | ||
| $25.77M+8.6% | $49.92M+60.8% | $36.25M+35.3% | $27.63M-5.4% | $23.72M-17.3% | ||
| -$68.89M-158% | $63.29M— | $20.73M+232% | -$12.58M+9.5% | -$26.75M-594% | ||
| -185.1%-154pp | 28.1%— | 13.7%+8.3pp | -12.5%-1.8pp | -30.9%-27.3pp | ||
| -$380K+60.5% | -$236K— | -$415K-188% | -$669K-208% | -$961K-287% | ||
| $418K-56.6% | $138K— | $433K+203% | $742K+215% | $963K+296% | ||
| -$68.47M-166% | $63.43M— | $21.16M+263% | -$11.83M+18.6% | -$25.78M-494% | ||
| -$15.32M-121% | $19.73M— | -$407K+93.7% | -$2.44M-198% | -$6.94M-209% | ||
| -$53.16M-182% | $43.7M+470% | $21.57M+74.9% | -$9.39M+44.9% | -$18.84M-797% | ||
| -142.8%-121pp | 19.4%+13.3pp | 14.3%+3.6pp | -9.3%+3.8pp | -21.7%-19.8pp | ||
| -$0.44-159% | $0.27— | $0.11+22.2% | -$0.10+23.1% | -$0.17-750% | ||
| -$0.44-159% | $0.28— | $0.11+22.2% | -$0.10+23.1% | -$0.17-750% | ||
| 127.8M+1.2% | 130.2M-1.1% | 130.8M-2.3% | 133.9M+1.0% | 126.3M-4.2% | ||
| 127.8M+1.2% | 126.7M-3.7% | 126.9M-4.3% | 126.9M-4.3% | 126.3M-4.2% | ||
| —— | $1.94M— | $922K— | $1.75M— | $6.57M— | ||
| $2.84M+8.3% | $2.79M+705% | $2.73M+689% | $2.68M+674% | $2.63M+658% | ||
| $38K+1,800% | -$98K— | $18K-65.4% | $73K+361% | $2K-91.3% | ||
| $159K+31.4% | $150K-63.6% | $140K— | $129K— | $121K— | ||
| -$68.89M-158% | $63.29M— | $20.73M+232% | -$12.58M+9.5% | -$26.75M-594% | ||
| -$64.72M-178% | $67.36M— | $24.76M+152% | -$8.84M+16.0% | -$23.3M-2,887% | ||
| -$64.72M-178% | $67.36M— | $24.76M+152% | -$8.84M+16.0% | -$23.3M-2,887% | ||
| -173.8%-147pp | 29.9%— | 16.4%+7.9pp | -8.8%-0.7pp | -26.9%-26.2pp | ||
| -$68.89M-158% | $63.29M— | $20.73M+232% | -$12.58M+9.5% | -$26.75M-594% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Organogenesis Holdings Inc.'s revenue?
- Organogenesis Holdings Inc. (ORGO) generated $514.7M in revenue over the trailing twelve months, up 12.2% year over year.
- Is Organogenesis Holdings Inc. profitable?
- Organogenesis Holdings Inc. reported $2.7M in net income over the trailing twelve months, a 0.5% net margin.
- What are Organogenesis Holdings Inc.'s profit margins?
- Gross margin is 75.9% and operating margin is 0.5%, with a 0.5% net margin.
- What is Organogenesis Holdings Inc.'s earnings per share?
- Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.16.
- Where does Organogenesis Holdings Inc.'s income statement data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
